MSD collaboration to investigate QBiotics’ lead molecule tigilanol tiglate in combination with KEYTRUDA(R) (pembrolizumab) Tigilanol tiglate is a novel, small…
MSD collaboration to investigate QBiotics’ lead molecule tigilanol tiglate in combination with KEYTRUDA(R) (pembrolizumab) Tigilanol tiglate is a novel, small…